Spring til hovedindhold

CanadaCanadaDelivra Health Brands Inc
(DHB)

· TSX Venture Exchange
· Valuta i CAD
TSX Venture Exchange
Senest
0,035
I dag %
0,00%
I dag +/-
0,000
Køb
0,035
Sælg
0,040
Højest
0,045
Lavest
0,030
Omsætning (Antal)
614.899
· TSX Venture Exchange
· Valuta i CAD
TSX Venture Exchange
· TSX Venture Exchange · Valuta i CAD
· Valuta i CAD
TSX Venture Exchange
Senest
0,035
Udvikling i dag
0,00%
0,000
Køb
0,035
Sælg
0,040
Højest
0,045
Lavest
0,030
Omsætning (Antal)
614.899
Q3
Kun PDF-version
37 dage siden

Ordredybde

Lukket
Antal
Køb
43.000
Sælg
Antal
57.000

Seneste handel

TidPrisAntalKøbereSælgere
----
Volumenvægtet gennemsnitspris
0,036
VWAP
0,036
Omsætning (CAD)
21.905

Husk på, at en investeret opsparing kan gå både op og ned i værdi. Selvom opsparing i aktier historisk set har givet gode langsigtede afkast, er det ingen garanti for fremtidige afkast. Der er en risiko for, at du ikke får de investerede penge tilbage.

Mæglerstatistik

Ingen data fundet

Corporate Actions

Næste begivenhed
Finanskalender er ikke tilgængelig
Tidligere begivenheder
2024 Q315. maj
2024 Q227. feb.
2024 Q128. nov. 2023
2023 Q418. okt. 2023
2023 Q323. maj 2023
Data hentes fra Quartr

Relaterede Produkter

Der findes ingen Nordnet Markets Certificates med det underliggende værdipapir. Vis andre Certificates

Andre har kigget på

Nyheder og Analyser

Nyheder og/eller generelle investeringsanbefalinger eller et uddrag af disse på denne side og i relaterede links er produceret og leveret af den angivne leverandør. Nordnet har ikke deltaget i udarbejdelsen af materialet, og vi har ikke gennemgået eller foretaget ændringer i materialet. Læs mere om investeringsanbefalinger.
Q3
Kun PDF-version
37 dage siden

Nyheder og Analyser

Nyheder og/eller generelle investeringsanbefalinger eller et uddrag af disse på denne side og i relaterede links er produceret og leveret af den angivne leverandør. Nordnet har ikke deltaget i udarbejdelsen af materialet, og vi har ikke gennemgået eller foretaget ændringer i materialet. Læs mere om investeringsanbefalinger.

Corporate Actions

Næste begivenhed
Finanskalender er ikke tilgængelig
Tidligere begivenheder
2024 Q315. maj
2024 Q227. feb.
2024 Q128. nov. 2023
2023 Q418. okt. 2023
2023 Q323. maj 2023
Data hentes fra Quartr

Relaterede Produkter

Der findes ingen Nordnet Markets Certificates med det underliggende værdipapir. Vis andre Certificates

Shareville

Deltag i samtalen med SharevilleBliv en del af vores forum for investorer. Følg andre, og diskuter aktier og fonde.
Log ind
  • 28. maj
    28. maj
    Delivra Health Brands Inc. (CVE:DHB) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. The CA$13m market-cap company posted a loss in its most recent financial year of CA$184k and a latest trailing-twelve-month loss of CA$708k leading to an even wider gap between loss and breakeven. Many investors are wondering about the rate at which Delivra Health Brands will turn a profit, with the big question being “when will the company breakeven?” Below we will provide a high-level summary of the industry analysts’ expectations for the company. Check out our latest analysis for Delivra Health Brands According to some industry analysts covering Delivra Health Brands, breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of CA$163k in 2025. So, the company is predicted to breakeven just over a year from now. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 167% is expected, which is rather optimistic! If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict. earnings-per-share-growth TSXV:DHB Earnings Per Share Growth May 23rd 2024 Given this is a high-level overview, we won’t go into details of Delivra Health Brands' upcoming projects, however, keep in mind that typically pharmaceuticals, depending on the stage of product development, have irregular periods of cash flow. This means, large upcoming growth rates are not abnormal as the company is beginning to reap the benefits of earlier investments. One thing we would like to bring into light with Delivra Health Brands is its relatively high level of debt. Generally, the rule of thumb is debt shouldn’t exceed 40% of your equity, which in Delivra Health Brands' case is 57%. A higher level of debt requires more stringent capital management which increases the risk in investing in the loss-making company.
  • 8. maj
    8. maj
    Automatisk teknisk analyse. Middels lang sikt, 7. mai 2024 Delivra Health Brands Inc viser en sterk utvikling innenfor en stigende trendkanal på mellomlang sikt. Stigende trender indikerer at bedriften er inne i en positiv utvikling og at kjøpsinteressen blant investorene er økende. Aksjen ga kjøpssignal fra en rektangelformasjon ved bruddet opp gjennom motstanden ved 0.04 . Videre oppgang til 0.05 eller mer er signalisert. Det er ingen motstand i kursdiagrammet og en videre oppgang indikeres. Ved reaksjoner tilbake har aksjen støtte ved cirka 0.03 . Det er dårlig likviditet i aksjen (handlet 95% av dagene, middel 0.01 mill kr per dag), noe som svekker analysen.
  • 7. maj
    To the moon friends! :)
    7. maj
    7. maj
    Do you know why it's going up?
    8. maj
    Only the positive direction with profitability comes to mind. The new leadership has successfully turned the tide.
  • 26. mar.
    26. mar.
    Delivra Health Brands Announces Adoption of a New Fixed Share Option Plan March 20, 2024 – Vancouver, British Columbia – Delivra Health Brands Inc. ("Delivra Health" or the "Company") (TSX-V: DHB; OTCQB: DHBUF), a consumer packaged goods company uniquely positioned in the health and wellness sector, announced today that its Board of Directors has adopted a new 10% fixed stock option plan (the “Stock Option Plan”), which has been approved by the TSX Venture Exchange ("TSXV"). The Stock Option Plan replaces the Company’s previous 10% fixed stock option plan, announced on July 14, 2020 (the "Predecessor Plan"). Under the Stock Option Plan, the Company may grant options to acquire up to 31,261,785 common shares of the Company, representing 10% of the Company’s current issued and outstanding common shares, subject to the terms and conditions prescribed by the TSXV, and applicable securities laws. Any options outstanding under the previous stock option plan will be governed by the new Stock Option Plan
  • 4. mar.
    4. mar.
    February 21, 2024 – Vancouver, British Columbia – Delivra Health Brands Inc. ("Delivra Health" or the "Company") (TSX-V: DHB; OTCQB: DHBUF), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Dream Water® brand will be launching a new line of sleep gummies in the Canadian market. Sleep Gummies are expected to be available to Company distributors, retailers and e-commerce channels in June 2024. The launch of Dream Water® Sleep Gummies in Canada is a significant milestone for the Company and will contribute to the Company’s sales growth plan and brand expansion in North America. The product will be available through Delivra Health’s national distribution partners in both retail and e-commerce channels and will improve Dream Water’s overall channel penetration by leveraging the Company’s expertise in branding, marketing, and distribution. Furthermore, this extension into a new functional format will allow the Dream Water® brand to meet the changing trends in consumer behavior. "We are pleased to announce that Dream Water® Sleep Gummies have been approved by Health Canada and will be available in Canadian retail and e-commerce locations in June of 2024, said Gord Davey, President and Chief Executive Officer of Delivra Health Brands. “The Canadian launch extends the success we have seen with this product in the United States in channels such as e-commerce, grocery, convenience and travel outlets, including all major US airports. We plan to continue our global rollout of Dream Water® products and provide Dream Water® Sleep Gummies to more territories in the near future."
Kommentarerne ovenfor kommer fra Nordnets sociale netværk Shareville og er ikke blevet redigeret eller gennemgået af Nordnet. Det betyder ikke, at Nordnet giver investeringsrådgivning eller investeringsanbefalinger. Nordnet påtager sig ikke noget ansvar for kommentarerne.
Q3
Kun PDF-version
37 dage siden

Nyheder og Analyser

Nyheder og/eller generelle investeringsanbefalinger eller et uddrag af disse på denne side og i relaterede links er produceret og leveret af den angivne leverandør. Nordnet har ikke deltaget i udarbejdelsen af materialet, og vi har ikke gennemgået eller foretaget ændringer i materialet. Læs mere om investeringsanbefalinger.

Shareville

Deltag i samtalen med SharevilleBliv en del af vores forum for investorer. Følg andre, og diskuter aktier og fonde.
Log ind
  • 28. maj
    28. maj
    Delivra Health Brands Inc. (CVE:DHB) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. The CA$13m market-cap company posted a loss in its most recent financial year of CA$184k and a latest trailing-twelve-month loss of CA$708k leading to an even wider gap between loss and breakeven. Many investors are wondering about the rate at which Delivra Health Brands will turn a profit, with the big question being “when will the company breakeven?” Below we will provide a high-level summary of the industry analysts’ expectations for the company. Check out our latest analysis for Delivra Health Brands According to some industry analysts covering Delivra Health Brands, breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of CA$163k in 2025. So, the company is predicted to breakeven just over a year from now. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 167% is expected, which is rather optimistic! If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict. earnings-per-share-growth TSXV:DHB Earnings Per Share Growth May 23rd 2024 Given this is a high-level overview, we won’t go into details of Delivra Health Brands' upcoming projects, however, keep in mind that typically pharmaceuticals, depending on the stage of product development, have irregular periods of cash flow. This means, large upcoming growth rates are not abnormal as the company is beginning to reap the benefits of earlier investments. One thing we would like to bring into light with Delivra Health Brands is its relatively high level of debt. Generally, the rule of thumb is debt shouldn’t exceed 40% of your equity, which in Delivra Health Brands' case is 57%. A higher level of debt requires more stringent capital management which increases the risk in investing in the loss-making company.
  • 8. maj
    8. maj
    Automatisk teknisk analyse. Middels lang sikt, 7. mai 2024 Delivra Health Brands Inc viser en sterk utvikling innenfor en stigende trendkanal på mellomlang sikt. Stigende trender indikerer at bedriften er inne i en positiv utvikling og at kjøpsinteressen blant investorene er økende. Aksjen ga kjøpssignal fra en rektangelformasjon ved bruddet opp gjennom motstanden ved 0.04 . Videre oppgang til 0.05 eller mer er signalisert. Det er ingen motstand i kursdiagrammet og en videre oppgang indikeres. Ved reaksjoner tilbake har aksjen støtte ved cirka 0.03 . Det er dårlig likviditet i aksjen (handlet 95% av dagene, middel 0.01 mill kr per dag), noe som svekker analysen.
  • 7. maj
    To the moon friends! :)
    7. maj
    7. maj
    Do you know why it's going up?
    8. maj
    Only the positive direction with profitability comes to mind. The new leadership has successfully turned the tide.
  • 26. mar.
    26. mar.
    Delivra Health Brands Announces Adoption of a New Fixed Share Option Plan March 20, 2024 – Vancouver, British Columbia – Delivra Health Brands Inc. ("Delivra Health" or the "Company") (TSX-V: DHB; OTCQB: DHBUF), a consumer packaged goods company uniquely positioned in the health and wellness sector, announced today that its Board of Directors has adopted a new 10% fixed stock option plan (the “Stock Option Plan”), which has been approved by the TSX Venture Exchange ("TSXV"). The Stock Option Plan replaces the Company’s previous 10% fixed stock option plan, announced on July 14, 2020 (the "Predecessor Plan"). Under the Stock Option Plan, the Company may grant options to acquire up to 31,261,785 common shares of the Company, representing 10% of the Company’s current issued and outstanding common shares, subject to the terms and conditions prescribed by the TSXV, and applicable securities laws. Any options outstanding under the previous stock option plan will be governed by the new Stock Option Plan
  • 4. mar.
    4. mar.
    February 21, 2024 – Vancouver, British Columbia – Delivra Health Brands Inc. ("Delivra Health" or the "Company") (TSX-V: DHB; OTCQB: DHBUF), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Dream Water® brand will be launching a new line of sleep gummies in the Canadian market. Sleep Gummies are expected to be available to Company distributors, retailers and e-commerce channels in June 2024. The launch of Dream Water® Sleep Gummies in Canada is a significant milestone for the Company and will contribute to the Company’s sales growth plan and brand expansion in North America. The product will be available through Delivra Health’s national distribution partners in both retail and e-commerce channels and will improve Dream Water’s overall channel penetration by leveraging the Company’s expertise in branding, marketing, and distribution. Furthermore, this extension into a new functional format will allow the Dream Water® brand to meet the changing trends in consumer behavior. "We are pleased to announce that Dream Water® Sleep Gummies have been approved by Health Canada and will be available in Canadian retail and e-commerce locations in June of 2024, said Gord Davey, President and Chief Executive Officer of Delivra Health Brands. “The Canadian launch extends the success we have seen with this product in the United States in channels such as e-commerce, grocery, convenience and travel outlets, including all major US airports. We plan to continue our global rollout of Dream Water® products and provide Dream Water® Sleep Gummies to more territories in the near future."
Kommentarerne ovenfor kommer fra Nordnets sociale netværk Shareville og er ikke blevet redigeret eller gennemgået af Nordnet. Det betyder ikke, at Nordnet giver investeringsrådgivning eller investeringsanbefalinger. Nordnet påtager sig ikke noget ansvar for kommentarerne.

Ordredybde

Lukket
Antal
Køb
43.000
Sælg
Antal
57.000

Seneste handel

TidPrisAntalKøbereSælgere
----
Volumenvægtet gennemsnitspris
0,036
VWAP
0,036
Omsætning (CAD)
21.905

Husk på, at en investeret opsparing kan gå både op og ned i værdi. Selvom opsparing i aktier historisk set har givet gode langsigtede afkast, er det ingen garanti for fremtidige afkast. Der er en risiko for, at du ikke får de investerede penge tilbage.

Mæglerstatistik

Ingen data fundet

Andre har kigget på

Corporate Actions

Næste begivenhed
Finanskalender er ikke tilgængelig
Tidligere begivenheder
2024 Q315. maj
2024 Q227. feb.
2024 Q128. nov. 2023
2023 Q418. okt. 2023
2023 Q323. maj 2023
Data hentes fra Quartr

Relaterede Produkter

Der findes ingen Nordnet Markets Certificates med det underliggende værdipapir. Vis andre Certificates